practices. The basic Chinese dietary approach is called qing dan, or clear-bland diet. It was developed throughout Chinese medical history by such great physicians as Sun Si-miao, Li Dong-yuan, and Zhu Dan-xi in their medical texts. Basically, Chinese medicine recommends foods without additives or strong added spices or flavorings, centering on grains, vegetables, seaweeds, and beans, along with small amounts of fish, fruit, nuts, and other animal products. Prostate cancer patients are asked to avoid heavy, greasy, overcooked foods; too much meat; milk products; sugar; and heavily spiced foods. Without the clear-bland diet, herbal medicine or acupuncture/moxa therapy will not be as effective.
Integrative Physician's Perspective
In this issue, our Integrative Tumor Board responders include two contributions that involve nutrition, one of which originates in a macrobiotic perspective (although it has been translated into a conventional medical setting and tone), while the other is written from a modern dietetics perspective. In addition, a third contributor discusses nutrition from the perspective of traditional Chinese medicine. One of our aims in soliciting this overlapping set of contributions was to investigate what differences or similarities might be found in the nutritional recommendations of practitioners in these differing perspectives.
Our case in this Tumor Board, contributed by Mark Schacht, succinctly presents a common scenario in the contemporary urologist's office: a retired gentleman who had been referred due to an elevated PSA during a routine physical. In this case, the PSA elevation was found to be due to prostate carcinoma, present in 25% of the prostate with no perineural invasion. This patient was, naturally, confronted with the multiple treatment options currently considered appropriate for early prostate cancer, and he elected to undergo brachytherapy. The patient eats a typical American diet and appears to have a rather high level of anxiety about his condition. What are the recommendations of our Tumor Board members for this individual?
Nutritional Oncology
Dr. Gordon Saxe kindly discussed both the medical options for treatment and nutritional objectives. Saxe's nutritional approach is based on his work with a diet that evolved out of the macrobiotic diet, along with the use of a stress-reduction model. His discussion of both the medical and the nutritional options is an excellent summary of the state of nutritional oncology considerations for prostate cancer today.
Saxe mentions both standard treatments for earlier stages of prostate cancer and treatments that are often delayed until later stages, such as androgen ablation and chemotherapy. He points out the side effects, complications, and reservations that many experts have with the many available conventional treatments, which make it so difficult for many patients, including the patient who is discussed in this Tumor Board, to make decisions about which therapy to pursue. I would note, in relation to Saxe's discussion of chemotherapy, which is usually used only later in the course of prostate cancer, that there are actually some new chemotherapy options that appear in early studies to have some impact on survival. The use of docetaxel in combination with estramustine phosphate has recently demonstrated improved survival relative to historical controls in patients with hormone-refractory metastatic disease (ie, no longer responsive to androgen ablation therapy). 1 Weekly docetaxel in men with hormone refractory disease was also shown to reduce PSA and measurable disease and to be reasonably well tolerated. 2 In addition, there is very interesting work going on in the areas of prostate cancer immunotherapy 3 and in the development of agents that target specific molecular defects in prostate cancer cells 4 ; such targeted therapy may represent the future of prostate cancer treatment but are obviously unavailable now. Chemotherapy and immunotherapy options, however, are far in the future for the patient under discussion, if, indeed, they would ever be needed at all. In Saxe's discussion of watchful waiting, he mentions the eradication of cancer as an ultimate or ideal goal but one that may not be truly necessary in this disease, in which many early-stage patients may die of other causes before their prostate cancer even becomes symptomatic. Nutrition and other integrative approaches certainly fit most easily into the watchful waiting situation, especially since the idea of going without treatment for cancer is too frightening for many to contemplate. The option of managing prostate cancer during the period of watchful waiting with an integrative modification is one that does not leave the patient without any care; at the same time, it does not subject the patient to unacceptable side effects of conventional treatment. If I could coin a phrase, what we and other integrative clinicians are advocating for prostate cancer patients is "actively participating watchful waiting." Those of us who approach cancer with integrative modalities do find that they can enhance quality of life and survivorship, but it has been my long-standing opinion that such approaches can in some situations buy the patient a critical edge: that care improves the chances for cure. Actively participating watchful waiting with prostate cancer appears to be emerging as one of those situations. Saxe's recent pilot study is an indication of just how valuable such active patient participation can be.
The scientific discussion in this contribution is excellent and deserves close study by those interested in the scientific background of nutritional oncology in prostate cancer. The migrant studies mentioned in the discussion of international variation in prostate cancer incidence and mortality, in which rates of prostate cancer increase 4-to 9-fold between the first and second generation of Japanese migrants to the United States, are one of the pieces of data that most strongly suggest an influence of lifestyle and diet on this disease. Another interesting perspective on the international variability of prostate cancer incidence is found in work that I have previously discussed in more detail, 5 which was published in the 1970s and 1980s. This work summarizes the occurrence in autopsy specimens of noninvasive "latent" prostate cancer (Gleason grades 1 or 2) in relation to invasive or infiltrative (Gleason 3-5) tumors in various countries. 6 Yatani and colleagues 6 found, in a survey of incidence of these tumors in different countries, that the latent type was found in 11% to 16% of autopsies in all countries, while the invasive type occurred in only 9% of Japanese, 14% in Hawaiians, 20% of Colombians, 18% in US Caucasians, and 24% of African Americans, corresponding well with the types of geographic patterns found in prostate cancer incidence. This was one of the important early studies that suggested that dietary and lifestyle influences may contribute to the promotion and progression of prostate cancer.
Saxe effectively reviews the data from other fields that support the adoption of a plant-based diet together with modifications in lifestyle for prostate cancer patients. He also outlines nutritional recommendations, which follow closely along the lines of an adapted macrobiotic diet, with interesting modifications such as the addition of dietary supplements, classically not a part of the macrobiotic regimen. He also makes the point that dietary changes of the magnitude he recommends are not easy to accomplish and need substantial education, support, and physician involvement. Having spent many years working clinically with an adapted macrobiotic diet program, 7 I would certainly affirm the need for patient support in accomplishing these dietary changes. I would also comment that the positive findings from his clinical study of patients with biochemical recurrence-the earliest potential manifestations of metastatic disease-do not surprise me in the least. Along with my research staff, I am now preparing for publication a longitudinal study in which the median survival time of a cohort of patients with stage D2 prostate cancer (distant metastases) who were treated in our clinic was calculated and was found to be approximately twice as long as that typically reported in the literature for this disease stage.
I concur with Saxe when he points out that the ultimate question faced by this patient is whether he values a possibly higher chance of long-term survival available with conventional treatment more than the risk of complications and consequently lower quality of life that treatment could entail. The patient also must decide what degree of certainty he is most comfortable with. Brachytherapy is a good choice in the present circumstances, but using dietary modification after his conventional treatment may help to ensure that the cancer does not recur. Because of his comorbidities-hypertension, peptic ulcer disease, and problems with knees and hernias possibly related to his weight-the plant-based diet offers this patient hope for improvements in health in many dimensions.
Nursing/Quality-of-Life Perspective
Susan Bauer-Wu has chosen an interesting approach to her discussion in that she has focused on the integrative approach to a single symptom that this patient may experience rather than discussing a comprehensive plan. This approach is quite refreshing, as it enables her to concentrate on the evidence-based analysis of the surprisingly large number of treatments that are potentially available for treatment of hot flashes in men being treated for prostate cancer. It is also somewhat surprising to see the large proportion of men receiving hormonal treatment who experience long-term problems with hot flashes. While hot flashes are certainly not a life-threatening complication of treatment, they are a significant issue in a patient's quality of life, and an integrative approach to their management is key not only to the nursing perspective but also to clinical care in general.
Bauer-Wu covers medications initially. Megestrol acetate, estrogens, clonidine, and SSRIs are all possible approaches, which do have some side effects. Possibly the most intriguing option she discusses is one that should have very minimal side effects: data from a pilot study of acupuncture in prostate cancer patients experiencing hot flashes from hormone therapy indicate a very high efficacy. This study clearly deserves further follow-up since it might provide an easily tolerated and effective option for a very large number of patients, if later studies replicate the success of the pilot trial.
Bauer-Wu also discusses options in the area of nutritional supplements such as vitamin E and soy isoflavones. In our clinical experience, we have observed both men and women with hot flashes who found soy isoflavones to be helpful, so it is intriguing to note that studies of isoflavones in men with prostate cancer are being conducted.
Black cohosh and other herbs with reported estrogenic properties are also discussed. While results of experiments in the herbal area have been mixed, it is important to note that more research on adequately characterized herbals is imperative for our understanding of their effects. We would draw the reader's attention to work now being done in the Program for Collaborative Research in the Pharmaceutical Sciences of the University of Illinois at Chicago, where both Associate Editor Charlotte Gyllenhaal and I hold academic positions. A major research program in this department is examining the mechanisms of action and chemistry of herbs used for menopause. Recent data from this program indicate that black cohosh does not, in fact, have an estrogenic effect, and it may have an impact on hot flashes through some other mechanism. 8 A well-characterized extract of black cohosh that has been standardized for maximum activity in control of hot flash symptoms, based on specific laboratory assays and mechanistic analysis, is now being prepared for use in clinical trials in this research program. Studies of this sort are, we feel, the only way in which the true potential of herbal remedies to contribute to health conditions can be demonstrated in an evidence-based manner that is also sensitive to the complex questions of herbal phytochemistry.
In the discussion of herbal medicines with potential application in prostate cancer, readers should also be aware of the recent (2001-2002) findings concerning the prostate cancer herbal remedy PC-SPES. Reviews in this journal last year 9,10 summarize both the intriguing properties of some of the herbs in this adaptation of a Chinese traditional formula and the drama that resulted from the discovery of the prescription medications diethylstilbestrol and warfarin contaminating the widely marketed herbal preparation. The PC-SPES drama serves as a warning to integrative practitioners and other health care workers, as well as patients, that the integrity of herbal products is always at risk in today's health care market, that standardized extracts are the most reliable product (although definitions of standardization need work, as noted elsewhere in this issue), and that thorough investigation of suppliers of herbal remedies is a must. Safety, as mentioned by Bauer-Wu, must be the foremost consideration in adoption of integrative methods that have lower levels of evidence-based validation.
Finally, Bauer-Wu discusses simple lifestyle modifications that are often overlooked, such as lowering room temperature and increasing physical activity. These interventions have a maximum level of safety and can often offer substantial comfort to the cancer patient with no risk of side effects or interaction with medications.
Nutrition
Stacy Kennedy, a registered dietitian and nutritional counselor, approaches prostate cancer from a more conventional nutritional perspective than does Gordon Saxe, a researcher-physician who has been working with the more alternative macrobiotic diet for many years. What is perhaps the most interesting feature of their 2 presentations is, in the end, the similarity of the conventional and macrobiotic recommendations for prostate cancer. Both call for plant-based diets, dietary supplements, and exercise. Kennedy's dietary counseling, in line with standard dietetic practice, does not call for the elimination of favorite foods in the diet but for a gradual replacement with more healthful foods. This is somewhat of a contrast to more alternative dietary approaches, which stress both elimination of nonhealthful foods and adoption of healthful practices.
Representing the evolution of nutritional thought in the United States, Kennedy makes exercise recommendations an integral part of her nutritional counseling, choosing the most recent recommendation of 60 minutes a day of moderate activity as the ideal figure. She also makes the very realistic point that this patient should more likely begin with 5 to 10 minutes daily of exercise, based on activities in which the patient finds some enjoyment. Certainly, clinical experience dictates that cancer patients undertaking exercise regimens may often need to take them slowly. Even with a slow start, however, exercise can have an enormously beneficial effect for the cancer patient. In my clinical practice, we have seen bedridden cancer patients who begin with only 30 seconds of tolerated exercise undergo very substantial rehabilitation, with a return to normal daily activities. Exercise thus makes a very substantial contribution to the patient's quality of life. Does it inhibit the growth of prostate cancer? Saxe points out that there is still confusion on this question and that physical activity is difficult to measure accurately. It might be worth noting that a prospective study of more than 7000 men in Britain found that exercise was associated with reduction of prostate cancer risk but that the intensity of exercise required for the protective effect was comparable to that experienced in playing sports rather than, for instance, short walks. 11 Thus, in contrast to the obvious quality-of-life benefits of exercise for prostate cancer patients, the inhibition of prostate cancer growth by exercise is an area that will need more research.
Kennedy raises a caution about the use of foods such as flax and walnuts that contain ALA, an omega-3 fatty acid. As she mentions, the question of the potential contribution of ALA to prostate cancer incidence is still unresolved. The possibility that ALA could be related to prostate cancer was first raised by Gann and colleagues, 12 who found in a prospective study that risk of prostate cancer was higher in men with elevated plasma ALA levels. Prostate cancer was also more common in men who ate red meat at least 5 times a week, although the correlation with ALA was strong even for men who had reduced intake of meat. 12 This is of interest since meat is one of the sources of ALA in the American diet, especially the diet before the 1980s when canola oil came into common use: approximately 1% of fatty acids in beef tallow consists of ALA. Other dietary sources include corn oil, butter, sunflower and olive oils, and soybean oil. Findings similar to those of Gann et al have been reported in other epidemiological studies. 13 However, other studies have shown opposite results. Freeman and colleagues 14 found in a case-control study of biopsy specimens that ALA levels were significantly lower when tumor extended to the surgical margin in the specimens and that cases had lower levels of omega-3 fatty acids than did controls. Animal studies generally demonstrate that ALA supplementation, or supplementation with ALA-containing foods (eg, flax seeds) diminishes tumor growth. 15 In addition, a pilot randomized trial of dietary fat restriction and flaxseed supplementation in men before surgery found that several biomarkers of prostate cancer aggressiveness were diminished in the experimental flaxseed diet group. 16 One point that should be made about this group of studies is that flaxseed is a different substance from ALA. Flaxseed contains lignans that may affect prostate cancer growth and thus use of the ground seeds is not the same as supplementation with, for instance, flaxseed oil, a good source of ALA. A better piece of advice for prostate cancer patients concerned about ALA might be to choose freshly ground flaxseeds rather than flaxseed oil (which can easily become oxidized in storage) as a supplement to the diet. Walnuts, similar to whole flaxseeds, contain other substances than simply ALA and may be of less concern than walnut oil, if eaten in moderation.
MBAT
The contribution of Peterson and Monti is of particular interest because the intervention they describe is currently the subject of a clinical trial being conducted through the Thomas Jefferson University Hospital. An admirable feature of their presentation is the initial specification of treatment goals, which are not always outlined in integrative treatment plans as well as conventional plans.
An interesting feature of the MBAT intervention is the use of a support group format that is gender segregated, although not disease segregated. In our clinical practice, support groups are conducted every week for patients who are undergoing chemotherapy; because patients with a great variety of diseases are treated at the clinic, these support groups are necessarily not segregated by gender or by disease. These groups are, of course, an excellent vehicle for providing counseling and support on coping with the problems of undergoing chemotherapy, but it is always interesting to notice the way in which patients affiliate with other patients who have the same disease. Patients seem to perceive that those undergoing exactly the set of physical and psychological problems as they face are the ones to whom they can most easily disclose feelings. Patients with similar diseases also provide important functions in modeling strategies of coping with diseasespecific issues.
A particular benefit of the gender-segregated support group format, however, and one that appears to be used in an especially fruitful way in the MBAT study, is the way in which the group's tasks are tailored to the unique ways in which each gender appears to react to a cancer diagnosis. For men, this reaction seems to be based more on task orientation and problem solving than on verbal discussion of emotional issues. This behavioral orientation is one to which art therapy may be particularly well suited. An additional benefit of the use of art therapy, as noted by Peterson and Monti, is the promotion of engagement with the therapeutic tasks. Cunningham et al 17 found engagement, or involvement with the work of a psychosocial intervention, to be a positive predictor of survival.
We will be watching the progress of the MBAT trial with great interest and look forward to hearing more from these authors as the trial progresses.
Traditional Chinese Medicine
The contribution by Rosenberg focuses on the use of pattern diagnosis in traditional Chinese medicine (TCM). Pattern diagnosis in TCM is founded on a perception of the importance of individualizing medical interventions. This perception, while it has obviously been a factor in TCM for hundreds of years, has been missing in Western medicine, which has opted for strategies such as standards of care, practice guidelines, and restricted formularies. One of the foundations of much of the integrative care movement is an insistence on the need for individualization; this is only one of the ways in which integrative care emulates the philosophies of TCM. This journal endorses the philosophy of individualizing treatment of cancer patients, and we hope to see future submissions in this area.
Rosenberg's presentation of the details of the various prostate cancer patterns and the herbal formulas prescribed for them emphasizes the need for expert diagnosis and prescription in the TCM treatment of specific diseases. His discussion of the contrasting usages of the fu zheng, or support the correct therapy, and the gong xie, or attack the disease, strategies is of interest. The gong xie therapies are toxic natural substances, analogous to chemotherapy drugs, and are generally unavailable in the United States. The fu zheng herbs, which would often be classified as "tonic" herbs, including ginseng, licorice, and others, are widely available here and are the ones most often applied in TCM therapy by a number of different practices. We have had clinical experience with a formula modeled on one of the TCM supportive herbal formulas in our chemotherapy unit, where we have observed that it is often very useful for patients suffering chemotherapy-related fatigue, an example of the strategies Rosenberg discusses in which the fu zheng herbs are used to support Western medical treatment rather than the TCM gong xie herbs.
Perhaps the most intriguing aspect of Rosenberg's contribution in the context of this Tumor Board is his discussion of dietary considerations. The clear-bland diet recommended in TCM for prostate cancer patients overlaps strongly with the dietary recommendations of Saxe and Kennedy. A diet centered on grains, vegetables, seaweeds, beans, and small amounts of fish, fruit, nuts, and animal products, which avoids heavy foods, meats, milk, and sugar is most similar to that discussed by Saxe but also shares much with the dietary principles discussed by Kennedy. The link with Saxe's recommendations is unsurprising since the macrobiotic diet is based on the traditional Japanese diet, which shares many features with other Asian diets. The overlap with Kennedy's dieteticsbased recommendations is somewhat more unexpected: perhaps it grows out of the way in which epidemiological insights have driven dietary research in the area of prostate cancer. Rosenberg's comment that without the clear-bland diet the effectiveness of herbal medicine and acupuncture will be endangered is telling. How many patients, with cancer and with other diseases, attempt to use herbal medicines or dietary supplements in the context of a standard American diet that promotes inflammation, atherosclerosis, and tumor growth, thereby undercutting the potential effectiveness of the naturally based therapies? I certainly don't know, but I suspect that the percentage of patients who adopt this practice nationwide is substantial. The TCM perspective on the "fruitlessness" of combining natural remedies with inappropriate diets is, again, one of the very relevant contributions of this ancient perspective to the evolution of the modern discipline of integrative medicine.
